The existence of a signalosome containing uPAR has been postulated by D'Allessio and Blasi [58] and the data obtained to date supports the hypothesis that ATN-658 disrupts the signalosome leading to global effects on integrin signaling and inhibition of tumor progression (Fig. 7). The gene discussed is PLAUR; the disease is neoplasm.